Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Cementos Bio-Bio's Enterprise Value is CLP538,838 Mil.
Cementos Bio-Bio's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was CLP48,204 Mil. Therefore, Cementos Bio-Bio's EV-to-EBIT ratio for today is 11.18.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Cementos Bio-Bio's Enterprise Value is CLP538,838 Mil.
Cementos Bio-Bio's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was CLP51,004 Mil. Therefore, Cementos Bio-Bio's EV-to-EBITDA ratio for today is 10.56.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Cementos Bio-Bio's Enterprise Value is CLP538,838 Mil.
Cementos Bio-Bio's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was CLP370,540 Mil. Therefore, Cementos Bio-Bio's EV-to-Revenue ratio for today is 1.45.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Cementos Bio-Bio's Enterprise Value is CLP538,838 Mil.
Cementos Bio-Bio's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was CLP46,673 Mil. Therefore, Cementos Bio-Bio's EV-to-FCF ratio for today is 11.55.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Cementos Bio-Bio (XSGO:CEMENTOS) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Cementos Bio-Bio's current Enterprise Value is CLP538,838 Mil.
Cementos Bio-Bio's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was CLP48,204 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Cementos Bio-Bio's current Enterprise Value is CLP538,838 Mil.
Cementos Bio-Bio's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was CLP51,004 Mil.
Cementos Bio-Bio's current Enterprise Value is CLP538,838 Mil.
Cementos Bio-Bio's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was CLP370,540 Mil.
Cementos Bio-Bio's current Enterprise Value is CLP538,838 Mil.
Cementos Bio-Bio's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was CLP60,017 Mil.
Cementos Bio-Bio's current Enterprise Value is CLP538,838 Mil.
Cementos Bio-Bio's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was CLP46,673 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cementos Bio-Bio Enterprise Value Related Terms
Cementos Bio-Bio Enterprise Value Historical Data
* Premium members only.
The historical data trend for Cementos Bio-Bio's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSGO:CEMENTOS vs CRH, VMC, MLM: Enterprise Value Comparison
For the Building Materials subindustry, Cementos Bio-Bio's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cementos Bio-Bio Enterprise Value vs Building Materials Industry
For the Building Materials industry and Basic Materials sector, Cementos Bio-Bio's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Cementos Bio-Bio's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Cementos Bio-Bio's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of CLP538,838 Mil mean?
Cementos Bio-Bio (XSGO:CEMENTOS) has a Enterprise Value of CLP538,838 Mil as of Jul. 02, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Cementos Bio-Bio and its competitors.
Is Cementos Bio-Bio's Enterprise Value too high?
Cementos Bio-Bio's current Enterprise Value is CLP538,838 Mil. Overall, Cementos Bio-Bio has a GF Score™ of 32/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cementos Bio-Bio's Enterprise Value compare to CRH and VMC?
Cementos Bio-Bio's Enterprise Value of CLP538,838 Mil can be compared against companies in the Building Materials industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Building Materials company?
A good Enterprise Value depends on the Building Materials industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Cementos Bio-Bio and its competitors. Cementos Bio-Bio's current Enterprise Value is CLP538,838 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cementos Bio-Bio stock overvalued right now?
Based on GuruFocus' analysis, Cementos Bio-Bio (XSGO:CEMENTOS) is currently considered Significantly Overvalued. The stock's GF Value™ is CLP740.61, compared to a current price of CLP1,730.00 — trading 133.6% above its estimated fair value. The current Enterprise Value is CLP538,838 Mil. Cementos Bio-Bio's overall GF Score™ is 32/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Cementos Bio-Bio (XSGO:CEMENTOS), the current Enterprise Value is CLP538,838 Mil as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cementos Bio-Bio (XSGO:CEMENTOS) Overvalued in 2026?
Based on GuruFocus' analysis, Cementos Bio-Bio stock appears to be overvalued.
The current stock price of CLP1,730.00 is trading 133.6% above its estimated GF Value™ of CLP740.61.
GuruFocus considers Cementos Bio-Bio to be Significantly Overvalued.
Key valuation signals for XSGO:CEMENTOS:
Enterprise Value: CLP538,838 Mil
GF Value™: CLP740.61 vs. price of CLP1,730.00 (133.6% above fair value)
No single metric tells the full story. See the XSGO:CEMENTOS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSGO:CEMENTOS has been successfully added to your 
